TRUE Private Wealth Advisors
Position in VRTX — Vertex Pharmaceuticals Inc / Ma
CIK 1667074
Salem, OR
Position in VRTX
as of Mar 31, 2026
· filed May 15, 2026
Position Value
$304,093
-$2,378 QoQ
Shares Held
681
+0.7% QoQ
Ownership
0.000%
of shares outstanding
% of Portfolio
0.12%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Jun 2020
8 quarters on record
Voting authority
Sole 0%
Shared 0%
None 100%
Common Shares in VRTX Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Mar 31, 2026TRUE Private Wealth Advisors holds $313,193 across 2 Biotechnology names. VRTX ranks #1 (97.1% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | VRTX |
Vertex Pharmaceuticals Inc / Ma
This page
|
681 | $304,093 | |
| 2 | NNVC |
Nanoviricides, Inc.
|
10,000 | $9,100 |
All Filings in VRTX
Export CSV
8 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $304,093 | 681 | Shares | Sole | 2026-05-15 | |
| 2025-12-31 | $306,471 | 676 | Shares | Sole | 2026-02-13 | |
| 2025-09-30 | $328,977 | 840 | Shares | Sole | 2025-11-14 | |
| 2025-06-30 | $420,714 | 945 | Shares | Sole | 2025-08-11 | |
| 2025-03-31 | $458,639 | 946 | Shares | Sole | 2025-05-15 | |
| 2020-12-31 | $4,017 | 17 | Shares | Sole | 2021-01-11 | |
| 2020-09-30 | $4,626 | 17 | Shares | Sole | 2020-10-09 | |
| 2020-06-30 | $4,935 | 17 | Shares | Sole | 2020-07-07 | |
| No filing history on record for this holder in this stock. | ||||||